XML 37 R19.htm IDEA: XBRL DOCUMENT
v3.22.4

Notes Payable | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes Payable |
Notes Payable | Note 11. Notes Payable Notes payable consisted of the following at December 31, 2022 and 2021 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2022 |  | 2021
Principal amount of CRYOPDP note payable | ​ | $ | — | ​ | $ | 1,133
Principal amount of Cell&Co notes payable | ​ |  | 415 | ​ |  | —
Less: discount on CRYOPDP note payable | ​ |  | — | ​ |  | (47)
Total notes payable | ​ |  | 415 | ​ |  | 1,086
Less: current portion of notes payable | ​ |  | (60) | ​ |  | —
Notes payable – long term | ​ | $ | 355 | ​ | $ | 1,086
​ Interest expense incurred in connection with the notes payable consisted of the following for the years ended December 31, 2022 and 2021 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended
​ | ​ | December 31,
​ |  | 2022 |  | 2021
Interest expense | ​ | $ | 14 | ​ | $ | —
Amortization of debt discount | ​ |  | 44 | ​ |  | 231
Total interest expense on notes payable | ​ | $ | 58 | ​ | $ | 231
​ CRYOPDP Note In connection with the acquisition of CRYOPDP, the Company assumed an interest free unsecured note payable of €4.0 million ($4.5 million) repayable in two installments. The first installment of €3.0 million ($3.4 million) was paid in December 2021 and the second installment of €1.0 million ($1.1 million) was paid in December 2022. A fair market value discount of €0.2 million ($0.3 million) was recorded and was amortized to interest expense using the effective interest method over the term of the note. Cell&Co Notes In connection with the acquisition of Cell&Co, the Company assumed two notes payable totaling €0.4 million ($0.4 million) bearing interest rates of 0.6% and 1.06%, respectively, payable quarterly, maturing in July 2027 and September 2030, respectively. Future note payments as of December 31, 2022 were as follows (in thousands):
​ | ​ | ​ | ​
Years Ending December 31, |  | Amount
2023 | ​ | $ | 60
2024 | ​ |  | 61
2025 | ​ |  | 61
2026 | ​ |  | 62
2027 | ​ |  | 59
Thereafter | ​ |  | 112
Total note maturities | ​ |  | 415
​

X
- Definition Entire disclosure of note payable. + References No definition available. + Details
Name: | cyrx_NotesPayableTextBlock
Namespace Prefix: | cyrx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_LongTermNotesPayableAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration